Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.
作者信息
Owen S A, Lunt M, Hider S L, Bruce I N, Barton A, Thomson W
机构信息
University of Manchester, Manchester, UK.
出版信息
Arthritis Rheum. 2010 Dec;62(12):3827-9. doi: 10.1002/art.27754.
PMID:20848569
Abstract
摘要
相似文献
1
Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.在类风湿关节炎患者队列中测试药物遗传学指标以预测甲氨蝶呤单药治疗的疗效和毒性。
Arthritis Rheum. 2010 Dec;62(12):3827-9. doi: 10.1002/art.27754.
2
The pharmacogenetics of methotrexate.甲氨蝶呤的药物遗传学
Rheumatology (Oxford). 2007 Oct;46(10):1520-4. doi: 10.1093/rheumatology/kem147. Epub 2007 Jun 24.
3
Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?甲氨蝶呤在类风湿关节炎中的药物基因组学：种族有影响吗？
J Rheumatol. 2008 Apr;35(4):550-2.
4
Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.功能多态性与初发类风湿关节炎中甲氨蝶呤治疗应答的关系。
Pharmacogenomics. 2010 Feb;11(2):163-75. doi: 10.2217/pgs.09.139.
5
Pharmacogenomics in rheumatoid arthritis.类风湿关节炎中的药物基因组学
Methods Mol Biol. 2008;448:413-35. doi: 10.1007/978-1-59745-205-2_14.
6
Methotrexate pharmacogenetics in rheumatoid arthritis.类风湿关节炎中甲氨蝶呤的药物遗传学。
Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S33-9. Epub 2010 Oct 28.
7
Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?药物遗传学能否更好地预测类风湿性关节炎患者甲氨蝶呤的毒性和疗效？
Ann Rheum Dis. 2003 Jan;62(1):4-9. doi: 10.1136/ard.62.1.4.
8
Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.了解甲氨蝶呤的作用机制：对类风湿关节炎治疗的启示。
Bull NYU Hosp Jt Dis. 2007;65(3):168-73.
9
Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.更新于 2011 年：来氟米特治疗类风湿关节炎——优势与不足。
Curr Opin Rheumatol. 2011 May;23(3):282-7. doi: 10.1097/BOR.0b013e328344fddb.
10
Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update.类风湿关节炎中甲氨蝶呤反应的药物遗传学：最新进展
Pharmacogenomics. 2020 Jan;21(1):3-6. doi: 10.2217/pgs-2019-0154.
引用本文的文献
1
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.叶酸代谢途径单核苷酸多态性：印度（亚洲）类风湿关节炎患者甲氨蝶呤反应的预测性药物遗传学标志物。
Pharmacogenomics. 2015 Dec;16(18):2019-34. doi: 10.2217/pgs.15.145. Epub 2015 Nov 30.
2
Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.甲氨蝶呤治疗慢性斑块状银屑病时的毒性：病例报告及文献复习。
Dermatol Ther (Heidelb). 2014 Dec;4(2):145-56. doi: 10.1007/s13555-014-0056-z. Epub 2014 Jun 19.
Zotero 插件